Copyright Reports & Markets. All rights reserved.

Global Diclofenac Active Pharmaceutical Ingredients Market Research Report 2021

Buy now

1 Diclofenac Active Pharmaceutical Ingredients Market Overview

  • 1.1 Product Overview and Scope of Diclofenac Active Pharmaceutical Ingredients
  • 1.2 Diclofenac Active Pharmaceutical Ingredients Segment by Type
    • 1.2.1 Global Diclofenac Active Pharmaceutical Ingredients Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Purity (99%-99.5%)
    • 1.2.3 Purity (above 99.5%)
    • 1.2.4 Purity (below 99 %)
  • 1.3 Diclofenac Active Pharmaceutical Ingredients Segment by Application
    • 1.3.1 Global Diclofenac Active Pharmaceutical Ingredients Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Reating Pain
    • 1.3.3 Fever
    • 1.3.4 Inflammation
    • 1.3.5 Others
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Diclofenac Active Pharmaceutical Ingredients Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Diclofenac Active Pharmaceutical Ingredients Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Diclofenac Active Pharmaceutical Ingredients Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Market Size by Region
    • 1.5.1 Global Diclofenac Active Pharmaceutical Ingredients Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Diclofenac Active Pharmaceutical Ingredients Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Diclofenac Active Pharmaceutical Ingredients Estimates and Forecasts (2016-2027)
    • 1.5.5 China Diclofenac Active Pharmaceutical Ingredients Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Diclofenac Active Pharmaceutical Ingredients Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Diclofenac Active Pharmaceutical Ingredients Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Diclofenac Active Pharmaceutical Ingredients Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Diclofenac Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Diclofenac Active Pharmaceutical Ingredients Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Diclofenac Active Pharmaceutical Ingredients Production Sites, Area Served, Product Types
  • 2.6 Diclofenac Active Pharmaceutical Ingredients Market Competitive Situation and Trends
    • 2.6.1 Diclofenac Active Pharmaceutical Ingredients Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Diclofenac Active Pharmaceutical Ingredients Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Diclofenac Active Pharmaceutical Ingredients Market Share by Region (2016-2021)
  • 3.2 Global Diclofenac Active Pharmaceutical Ingredients Revenue Market Share by Region (2016-2021)
  • 3.3 Global Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Diclofenac Active Pharmaceutical Ingredients Production
    • 3.4.1 North America Diclofenac Active Pharmaceutical Ingredients Production Growth Rate (2016-2021)
    • 3.4.2 North America Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Diclofenac Active Pharmaceutical Ingredients Production
    • 3.5.1 Europe Diclofenac Active Pharmaceutical Ingredients Production Growth Rate (2016-2021)
    • 3.5.2 Europe Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Diclofenac Active Pharmaceutical Ingredients Production
    • 3.6.1 China Diclofenac Active Pharmaceutical Ingredients Production Growth Rate (2016-2021)
    • 3.6.2 China Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Diclofenac Active Pharmaceutical Ingredients Production
    • 3.7.1 Japan Diclofenac Active Pharmaceutical Ingredients Production Growth Rate (2016-2021)
    • 3.7.2 Japan Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Diclofenac Active Pharmaceutical Ingredients Consumption by Region

  • 4.1 Global Diclofenac Active Pharmaceutical Ingredients Consumption by Region
    • 4.1.1 Global Diclofenac Active Pharmaceutical Ingredients Consumption by Region
    • 4.1.2 Global Diclofenac Active Pharmaceutical Ingredients Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Diclofenac Active Pharmaceutical Ingredients Consumption by Country
    • 4.2.2 United States
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Diclofenac Active Pharmaceutical Ingredients Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Diclofenac Active Pharmaceutical Ingredients Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Diclofenac Active Pharmaceutical Ingredients Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Diclofenac Active Pharmaceutical Ingredients Production Market Share by Type (2016-2021)
  • 5.2 Global Diclofenac Active Pharmaceutical Ingredients Revenue Market Share by Type (2016-2021)
  • 5.3 Global Diclofenac Active Pharmaceutical Ingredients Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Diclofenac Active Pharmaceutical Ingredients Consumption Market Share by Application (2016-2021)
  • 6.2 Global Diclofenac Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Granules India Limited
    • 7.1.1 Granules India Limited Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.1.2 Granules India Limited Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.1.3 Granules India Limited Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Granules India Limited Main Business and Markets Served
    • 7.1.5 Granules India Limited Recent Developments/Updates
  • 7.2 Huagang Pharm
    • 7.2.1 Huagang Pharm Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.2.2 Huagang Pharm Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.2.3 Huagang Pharm Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Huagang Pharm Main Business and Markets Served
    • 7.2.5 Huagang Pharm Recent Developments/Updates
  • 7.3 Hebei Jiheng Pharmaceutical
    • 7.3.1 Hebei Jiheng Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.3.2 Hebei Jiheng Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.3.3 Hebei Jiheng Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Hebei Jiheng Pharmaceutical Main Business and Markets Served
    • 7.3.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
  • 7.4 Zhejiang Kangle Pharmaceutical
    • 7.4.1 Zhejiang Kangle Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.4.2 Zhejiang Kangle Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.4.3 Zhejiang Kangle Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Zhejiang Kangle Pharmaceutical Main Business and Markets Served
    • 7.4.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
  • 7.5 Jingye Group
    • 7.5.1 Jingye Group Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.5.2 Jingye Group Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.5.3 Jingye Group Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Jingye Group Main Business and Markets Served
    • 7.5.5 Jingye Group Recent Developments/Updates
  • 7.6 Hunan Zhongnan Pharmaceutical
    • 7.6.1 Hunan Zhongnan Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.6.2 Hunan Zhongnan Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.6.3 Hunan Zhongnan Pharmaceutical Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Hunan Zhongnan Pharmaceutical Main Business and Markets Served
    • 7.6.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
  • 7.7 Elam Pharma Pvt. Ltd. (EPPL)
    • 7.7.1 Elam Pharma Pvt. Ltd. (EPPL) Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.7.2 Elam Pharma Pvt. Ltd. (EPPL) Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.7.3 Elam Pharma Pvt. Ltd. (EPPL) Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Elam Pharma Pvt. Ltd. (EPPL) Main Business and Markets Served
    • 7.7.5 Elam Pharma Pvt. Ltd. (EPPL) Recent Developments/Updates
  • 7.8 Watanabe Chemical Co., Ltd
    • 7.8.1 Watanabe Chemical Co., Ltd Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.8.2 Watanabe Chemical Co., Ltd Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.8.3 Watanabe Chemical Co., Ltd Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Watanabe Chemical Co., Ltd Main Business and Markets Served
    • 7.7.5 Watanabe Chemical Co., Ltd Recent Developments/Updates
  • 7.9 Virchow Laboratories Limited
    • 7.9.1 Virchow Laboratories Limited Diclofenac Active Pharmaceutical Ingredients Corporation Information
    • 7.9.2 Virchow Laboratories Limited Diclofenac Active Pharmaceutical Ingredients Product Portfolio
    • 7.9.3 Virchow Laboratories Limited Diclofenac Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Virchow Laboratories Limited Main Business and Markets Served
    • 7.9.5 Virchow Laboratories Limited Recent Developments/Updates

8 Diclofenac Active Pharmaceutical Ingredients Manufacturing Cost Analysis

  • 8.1 Diclofenac Active Pharmaceutical Ingredients Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Diclofenac Active Pharmaceutical Ingredients
  • 8.4 Diclofenac Active Pharmaceutical Ingredients Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Diclofenac Active Pharmaceutical Ingredients Distributors List
  • 9.3 Diclofenac Active Pharmaceutical Ingredients Customers

10 Market Dynamics

  • 10.1 Diclofenac Active Pharmaceutical Ingredients Industry Trends
  • 10.2 Diclofenac Active Pharmaceutical Ingredients Growth Drivers
  • 10.3 Diclofenac Active Pharmaceutical Ingredients Market Challenges
  • 10.4 Diclofenac Active Pharmaceutical Ingredients Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Diclofenac Active Pharmaceutical Ingredients by Region (2022-2027)
  • 11.2 North America Diclofenac Active Pharmaceutical Ingredients Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Diclofenac Active Pharmaceutical Ingredients Production, Revenue Forecast (2022-2027)
  • 11.4 China Diclofenac Active Pharmaceutical Ingredients Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Diclofenac Active Pharmaceutical Ingredients Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Diclofenac Active Pharmaceutical Ingredients
  • 12.2 North America Forecasted Consumption of Diclofenac Active Pharmaceutical Ingredients by Country
  • 12.3 Europe Market Forecasted Consumption of Diclofenac Active Pharmaceutical Ingredients by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Diclofenac Active Pharmaceutical Ingredients by Region
  • 12.5 Latin America Forecasted Consumption of Diclofenac Active Pharmaceutical Ingredients by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Diclofenac Active Pharmaceutical Ingredients by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Diclofenac Active Pharmaceutical Ingredients by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Diclofenac Active Pharmaceutical Ingredients by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Diclofenac Active Pharmaceutical Ingredients by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Purity (99%-99.5%)
    Purity (above 99.5%)
    Purity (below 99 %)

    Segment by Application
    Reating Pain
    Fever
    Inflammation
    Others

    By Company
    Granules India Limited
    Huagang Pharm
    Hebei Jiheng Pharmaceutical
    Zhejiang Kangle Pharmaceutical
    Jingye Group
    Hunan Zhongnan Pharmaceutical
    Elam Pharma Pvt. Ltd. (EPPL)
    Watanabe Chemical Co., Ltd
    Virchow Laboratories Limited

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now